Financial Incentives to Improve Medication Adherence
NCT04191876 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2023-09-21
Summary
Medication adherence is a challenge in all of medicine and is associated with multiple negative outcomes. Strategies to better measure and enhance adherence to medication are urgent and necessary to minimize unwanted health outcomes, hospitalizations, poorer quality of life and excessive costs for individuals, insurers and caregivers. Recently, behavioral economics-based approaches have emerged as a promising tool to address this unmet need, but its effectiveness in oral antipsychotic treatment remains to be assessed. For this project, investigators will use an app that offers financial incentives to increase compliance for patients with chronic diseases. Investigators intend to enroll 25 patients in a pilot project to assess feasibility of offering financial incentives to improve medication adherence in severe mental illness.
Conditions
- Schizophrenia
- Schizo Affective Disorder
- Bipolar Disorder
- Depression
Interventions
- OTHER
-
Wellth - Financial Incentives
Patients who are willing to participate will be offered financial incentives for medication adherence through an app (Wellth) over 10 weeks.
Sponsors & Collaborators
-
Northwell Health
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-11-01
- Primary Completion
- 2020-05-30
- Completion
- 2022-03-02
Countries
- United States
Study Locations
More Related Trials
-
Real-world Lithium Intake
NCT07167563 ·Status: RECRUITING
-
Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder
NCT01981811 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effectiveness RCT of Customized Adherence Enhancement
NCT04622150 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effectiveness of Family-Focused Treatment Plus Pharmacotherapy for Bipolar Disorder in Adolescents
NCT00332098 ·Status: COMPLETED ·Phase: PHASE3
-
Personal Adherence Evaluation of Medication Use for Adult Bipolar Disorder Patients
NCT00763581 ·Status: COMPLETED
-
Customized Medication Adherence Enhancement for Treating Adults With Bipolar Disorder
NCT00763919 ·Status: COMPLETED ·Phase: NA
-
LiveWell: A Mobile Intervention for Bipolar Disorder
NCT03088462 ·Status: COMPLETED ·Phase: NA
-
A Preliminary Study of the Effectiveness and Tolerability of Aripiprazole in Bipolar Depression
NCT00363337 ·Status: COMPLETED ·Phase: PHASE4
-
Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
NCT01710709 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
NCT03643159 ·Status: TERMINATED ·Phase: PHASE4
-
Implementing Health Plan-Level Care Management for Solo & Small Practices
NCT02041962 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
NCT01072630 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of MEM 1003 Versus Placebo for the Treatment of Patients With Bipolar I Disorder
NCT00374920 ·Status: COMPLETED ·Phase: PHASE2
-
Improving Adherence in Adolescents and Young Adults With Bipolar Disorder
NCT04348604 ·Status: COMPLETED ·Phase: NA
-
Adapting the Bipolar Care Model for Chronic Care Management in Community-based Health Care Sites
NCT00747201 ·Status: COMPLETED ·Phase: NA
-
A Close Examination of Patient Experiences in Bipolar Disorder Clinical Trials
NCT05891639 ·Status: NOT_YET_RECRUITING
-
Benefits Management for People With Psychiatric Disabilities
NCT01329393 ·Status: COMPLETED ·Phase: PHASE1
-
Phase IV Long-term Maintenance Study of Aripiprazole in the Treatment of Irritability Associated With Autistic Disorder
NCT01227668 ·Status: COMPLETED ·Phase: PHASE4
-
Does Bipolar Disease Program (BDP) Intervention Improve Long Term Manic and Depressive Symptoms.
NCT00007761 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating a New Iloperidone Titration Scheme in Bipolar I Disorder or Schizophrenia
NCT04127058 ·Status: COMPLETED ·Phase: PHASE1
-
Aripiprazole Treatment of Bipolar Depression
NCT00198198 ·Status: COMPLETED ·Phase: PHASE4
-
Understanding Treatment Adherence Among Individuals With Rapid Cycling Bipolar Disorder
NCT00183703 ·Status: COMPLETED
-
Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic Syndrome
NCT00857818 ·Status: TERMINATED ·Phase: PHASE3
-
A First In Human Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of PF-04455242 In Single Rising Doses In Healthy Adult Volunteers
NCT00938301 ·Status: COMPLETED ·Phase: PHASE1
-
Aripiprazole in the Treatment of Bipolar Depression
NCT00226317 ·Status: COMPLETED ·Phase: NA